These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization. Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073 [TBL] [Abstract][Full Text] [Related]
6. Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. Bloch SB; Lund-Andersen H; Sander B; Larsen M Am J Ophthalmol; 2013 Jul; 156(1):116-124.e1. PubMed ID: 23664150 [TBL] [Abstract][Full Text] [Related]
7. Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab. Wolf A; Rüping J; Neubauer AS; Mayer W; Ulbig M; Haritoglou C; Holz FG; Eter N; Kampik A Retina; 2013 Oct; 33(9):1843-9. PubMed ID: 23598795 [TBL] [Abstract][Full Text] [Related]
8. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309 [TBL] [Abstract][Full Text] [Related]
10. Association between foveal microstructure and visual outcome in age-related macular degeneration. Shin HJ; Chung H; Kim HC Retina; 2011 Sep; 31(8):1627-36. PubMed ID: 21606888 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity. Saito M; Iida T; Kano M Retina; 2012 Jul; 32(7):1250-9. PubMed ID: 22446886 [TBL] [Abstract][Full Text] [Related]
12. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752 [TBL] [Abstract][Full Text] [Related]
13. Retinal pigment epithelial cell loss assessed by fundus autofluorescence imaging in neovascular age-related macular degeneration. Kumar N; Mrejen S; Fung AT; Marsiglia M; Loh BK; Spaide RF Ophthalmology; 2013 Feb; 120(2):334-41. PubMed ID: 23137630 [TBL] [Abstract][Full Text] [Related]
14. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Shah VP; Shah SA; Mrejen S; Freund KB Retina; 2014 Jul; 34(7):1281-8. PubMed ID: 24695062 [TBL] [Abstract][Full Text] [Related]
15. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion. Hoerster R; Muether PS; Sitnilska V; Kirchhof B; Fauser S Retina; 2014 Sep; 34(9):1767-73. PubMed ID: 24936942 [TBL] [Abstract][Full Text] [Related]
16. Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment. Kuehlewein L; Dustin L; Sagong M; Hariri A; Mendes TS; Rofagha S; Bhisitkul RB; Sadda SR Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):224-31. PubMed ID: 26985795 [TBL] [Abstract][Full Text] [Related]
17. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration. Schütze C; Wedl M; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth U Am J Ophthalmol; 2015 Jun; 159(6):1100-1114.e1. PubMed ID: 25769245 [TBL] [Abstract][Full Text] [Related]
18. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results. Dunavoelgyi R; Sacu S; Eibenberger K; Palkovits S; Leydolt C; Pruente C; Schmidt-Erfurth U Retina; 2012 Sep; 32(8):1471-9. PubMed ID: 22414958 [TBL] [Abstract][Full Text] [Related]
19. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500 [TBL] [Abstract][Full Text] [Related]